By Jeff Montgomery ( February 6, 2023, 5:23 PM EST) -- An Italian pharmaceutical company chosen to serve as a bidder-to-beat for a later-canceled Delaware Chapter 11 auction of drug research firm PhaseBio Pharmaceuticals still deserves a $2 million breakup fee based on the proposal's benefit to the estate, a bankruptcy judge ruled on Monday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.